BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Perazella MA. Advanced kidney disease, gadolinium and nephrogenic systemic fibrosis: the perfect storm. Curr Opin Nephrol Hypertens 2009;18:519-25. [PMID: 19623065 DOI: 10.1097/MNH.0b013e3283309660] [Cited by in Crossref: 34] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Chang J, Ronco C, Rosner MH. Computerized decision support systems: improving patient safety in nephrology. Nat Rev Nephrol 2011;7:348-55. [PMID: 21502973 DOI: 10.1038/nrneph.2011.50] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
2 Daldrup-Link HE, Theruvath AJ, Rashidi A, Iv M, Majzner RG, Spunt SL, Goodman S, Moseley M. How to stop using gadolinium chelates for magnetic resonance imaging: clinical-translational experiences with ferumoxytol. Pediatr Radiol 2021. [PMID: 34046709 DOI: 10.1007/s00247-021-05098-5] [Reference Citation Analysis]
3 Smorodinsky E, Ansdell DS, Foster ZW, Mazhar SM, Cruite I, Wolfson T, Sugay SB, Iussich G, Shiehmorteza M, Kono Y, Kuo A, Sirlin CB. Risk of nephrogenic systemic fibrosis is low in patients with chronic liver disease exposed to gadolinium-based contrast agents. J Magn Reson Imaging 2015;41:1259-67. [PMID: 24811860 DOI: 10.1002/jmri.24650] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
4 Chopra T, Kandukurti K, Shah S, Ahmed R, Panesar M. Understanding nephrogenic systemic fibrosis. Int J Nephrol. 2012;2012:912189. [PMID: 23193473 DOI: 10.1155/2012/912189] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
5 Yu X, Zheng Y, Deng Y, Li J, Guo R, Su M, Ming D, Lin Z, Zhang J, Su Z. Serum Interleukin (IL)-9 and IL-10, but not T-Helper 9 (Th9) Cells, are Associated With Survival of Patients With Acute-on-Chronic Hepatitis B Liver Failure. Medicine (Baltimore) 2016;95:e3405. [PMID: 27100428 DOI: 10.1097/MD.0000000000003405] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
6 Pennig L, Kabbasch C, Hoyer UCI, Lennartz S, Zopfs D, Goertz L, Laukamp KR, Wagner A, Grunz JP, Doerner J, Persigehl T, Weiss K, Borggrefe J. Relaxation-Enhanced Angiography Without Contrast and Triggering (REACT) for Fast Imaging of Extracranial Arteries in Acute Ischemic Stroke at 3 T. Clin Neuroradiol 2021;31:815-26. [PMID: 33026511 DOI: 10.1007/s00062-020-00963-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Mayr A, Klug G, Reinstadler SJ, Feistritzer HJ, Reindl M, Kremser C, Kranewitter C, Bonaros N, Friedrich G, Feuchtner G, Metzler B. Is MRI equivalent to CT in the guidance of TAVR? A pilot study. Eur Radiol 2018;28:4625-34. [PMID: 29736853 DOI: 10.1007/s00330-018-5386-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
8 Do C, Barnes JL, Tan C, Wagner B. Type of MRI contrast, tissue gadolinium, and fibrosis. Am J Physiol Renal Physiol 2014;307:F844-55. [PMID: 25100280 DOI: 10.1152/ajprenal.00379.2014] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.8] [Reference Citation Analysis]
9 Pennig L, Wagner A, Weiss K, Lennartz S, Huntgeburth M, Hickethier T, Maintz D, Naehle CP, Bunck AC, Doerner J. Comparison of a novel Compressed SENSE accelerated 3D modified relaxation-enhanced angiography without contrast and triggering with CE-MRA in imaging of the thoracic aorta. Int J Cardiovasc Imaging 2021;37:315-29. [PMID: 32852711 DOI: 10.1007/s10554-020-01979-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Kasper JY, Hermanns MI, Cavelius C, Kraegeloh A, Jung T, Danzebrink R, Unger RE, Kirkpatrick CJ. The role of the intestinal microvasculature in inflammatory bowel disease: studies with a modified Caco-2 model including endothelial cells resembling the intestinal barrier in vitro. Int J Nanomedicine 2016;11:6353-64. [PMID: 27994454 DOI: 10.2147/IJN.S92608] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
11 Abdel-Kader K, Patel PR, Kallen AJ, Sinkowitz-Cochran RL, Bolton WK, Unruh ML. Nephrogenic systemic fibrosis: a survey of nephrologists' perceptions and practices. Clin J Am Soc Nephrol 2010;5:964-71. [PMID: 20299369 DOI: 10.2215/CJN.00140110] [Cited by in Crossref: 7] [Article Influence: 0.6] [Reference Citation Analysis]
12 Hartung MP, Grist TM, François CJ. Magnetic resonance angiography: current status and future directions. J Cardiovasc Magn Reson 2011;13:19. [PMID: 21388544 DOI: 10.1186/1532-429X-13-19] [Cited by in Crossref: 104] [Cited by in F6Publishing: 38] [Article Influence: 9.5] [Reference Citation Analysis]
13 Yu X, Guo R, Ming D, Deng Y, Su M, Lin C, Li J, Lin Z, Su Z. The Transforming Growth Factor β1/Interleukin-31 Pathway Is Upregulated in Patients with Hepatitis B Virus-Related Acute-on-Chronic Liver Failure and Is Associated with Disease Severity and Survival. Clin Vaccine Immunol 2015;22:484-92. [PMID: 25716231 DOI: 10.1128/CVI.00649-14] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
14 Pennig L, Wagner A, Weiss K, Lennartz S, Grunz JP, Maintz D, Laukamp KR, Hickethier T, Naehle CP, Bunck AC, Doerner J. Imaging of the pulmonary vasculature in congenital heart disease without gadolinium contrast: Intraindividual comparison of a novel Compressed SENSE accelerated 3D modified REACT with 4D contrast-enhanced magnetic resonance angiography. J Cardiovasc Magn Reson 2020;22:8. [PMID: 31969137 DOI: 10.1186/s12968-019-0591-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
15 Yang L, Fu S, Cai Z, Liu L, Xia C, Gong Q, Song B, Ai H. Integration of PEG-conjugated gadolinium complex and superparamagnetic iron oxide nanoparticles as T 1-T 2 dual-mode magnetic resonance imaging probes. Regen Biomater 2021;8:rbab064. [PMID: 34881046 DOI: 10.1093/rb/rbab064] [Reference Citation Analysis]
16 Timms L, Zhou T, Lyu Y, Qiao J, Mishra V, Lahoud RM, Jayaraman GV, Allegretti AS, Drew D, Seethamraju RT, Harisinghani M, Sridhar S. Ferumoxytol-enhanced ultrashort TE MRA and quantitative morphometry of the human kidney vasculature. Abdom Radiol (NY) 2021;46:3288-300. [PMID: 33666735 DOI: 10.1007/s00261-021-02984-2] [Reference Citation Analysis]
17 Chen TK, Knicely DH, Grams ME. Chronic Kidney Disease Diagnosis and Management: A Review. JAMA 2019;322:1294-304. [PMID: 31573641 DOI: 10.1001/jama.2019.14745] [Cited by in Crossref: 129] [Cited by in F6Publishing: 107] [Article Influence: 43.0] [Reference Citation Analysis]
18 Lusic H, Grinstaff MW. X-ray-computed tomography contrast agents. Chem Rev. 2013;113:1641-1666. [PMID: 23210836 DOI: 10.1021/cr200358s] [Cited by in Crossref: 520] [Cited by in F6Publishing: 426] [Article Influence: 52.0] [Reference Citation Analysis]
19 Bennett CL, Starko KM, Thomsen HS, Cowper S, Sartor O, Macdougall IC, Qureshi ZP, Bookstaver PB, Miller AD, Norris LB, Xirasagar S, Trenery A, Lopez I, Kahn A, Murday A, Luminari S, Cournoyer D, Locatelli F, Ray P, Mattison DR. Linking drugs to obscure illnesses: lessons from pure red cell aplasia, nephrogenic systemic fibrosis, and Reye's syndrome. a report from the Southern Network on Adverse Reactions (SONAR). J Gen Intern Med 2012;27:1697-703. [PMID: 22692632 DOI: 10.1007/s11606-012-2098-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]